In managing cerebral edema, what PaCO2 target is generally used?

• A. 15-20 mm Hg
• B. 40-45 mm Hg
• C. 30-35 mm Hg
• D. 45-50 mm Hg

Answer: (C)

In cerebral edema, PaCO2 directly influences cerebral blood flow through the vessels’ CO2 sensitivity. Lowering PaCO2 causes cerebral vasoconstriction, which reduces cerebral blood volume and lowers intracranial pressure. The commonly used target is about 30-35 mmHg, providing enough vasoconstriction to reduce ICP without risking significant brain ischemia from excessive vasoconstriction.

This is typically a short-term, tightly monitored strategy because pushing PaCO2 too low can compromise oxygen delivery to brain tissue, while not lowering it enough won’t adequately reduce ICP. Restoring PaCO2 to normal (around 40-45 mmHg) or higher (hypercapnia) would not help reduce ICP and can worsen edema due to vasodilation. Conversely, pausing too low (like 15-20 mmHg) could dangerously reduce cerebral perfusion.